Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 5 (2008), Issue 2 (February)

1. Radiation therapy to non-iatrogenic subcutaneous metastasis in hepatocellular carcinoma: results of a case series.
   Br J Radiol, 81(962): 143-50. [Abstract] [Full-text]
2. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.
   Cancer Res, 68(3): 946-55. [Abstract] [Full-text]
3. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
   Cancer Res, 68(3): 683-92. [Abstract] [Full-text]
4. Phacomatosis cesioflammea with unilateral lipohypoplasia.
   Am J Med Genet A, 146(4): 492-5. [Abstract] [Full-text]
5. Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice.
   Clin Vaccine Immunol, 15(2): 376-8. [Abstract] [Full-text]
6. A dicyanotriterpenoid induces cytoprotective enzymes and reduces multiplicity of skin tumors in UV-irradiated mice.
   Biochem Biophys Res Commun, 367(4): 859-65. [Abstract] [Full-text]
7. Metastatic rhabdoid melanoma: report of a case with a comparative review of the literature.
   J Cutan Pathol, 35(3): 337-42. [Abstract] [Full-text]
8. Solid apocrine carcinoma of the skin: report of a rare adnexal neoplasm mimicking lobular breast carcinoma.
   J Cutan Pathol, 35(3): 332-6. [Abstract] [Full-text]
9. A case of cutaneous symplastic leiomyoma - a rare variant of cutaneous pilar leiomyoma.
   J Cutan Pathol, 35(3): 329-31. [Abstract] [Full-text]
10. Acantholytic dyskeratotic acanthoma: a variant of a benign keratosis.
    J Cutan Pathol, 35(3): 298-301. [Abstract] [Full-text]
11. Immunohistochemical detection of XIAP in melanoma.
    J Cutan Pathol, 35(3): 292-7. [Abstract] [Full-text]
12. High numbers of human skin cancers express MMP2 and several integrin genes.
    J Cutan Pathol, 35(3): 285-91. [Abstract] [Full-text]
13. Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.
    J Cutan Pathol, 35(3): 273-7. [Abstract] [Full-text]
14. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.
    Proc Natl Acad Sci U S A, 105(5): 1674-9. [Abstract] [Full-text]
15. Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry.
    Ann Surg Oncol, 15(3): 934-40. [Abstract] [Full-text]
16. A unique case of a malignant Sertoli cell tumour with cutaneous metastasis.
    ScientificWorldJournal, 8: 95-7. [Abstract] [Full-text]
17. Human skin keloid fibroblasts display bioenergetics of cancer cells.
    J Invest Dermatol, 128(3): 702-9. [Abstract] [Full-text]
18. A new disorder in UV-induced skin cancer with defective DNA repair distinct from xeroderma pigmentosum or Cockayne syndrome.
    J Invest Dermatol, 128(3): 694-701. [Abstract] [Full-text]
19. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
    J Invest Dermatol, 128(3): 587-93. [Abstract] [Full-text]
20. Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma.
    J Invest Dermatol, 128(3): 676-84. [Abstract] [Full-text]
21. Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.
    J Invest Dermatol, 128(3): 575-86. [Abstract] [Full-text]
22. Diagnosis and management of sebaceous carcinoma: an Australian experience.
    ANZ J Surg, 78(3): 158-63. [Abstract] [Full-text]
23. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Oncogene, 27(8): 1087-94. [Abstract] [Full-text]
24. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Ann Surg Oncol, 15(2): 630-7. [Abstract] [Full-text]
25. Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
    J Clin Oncol, 26(6): 955-62. [Abstract] [Full-text]
26. Spontaneous involution of congenital melanocytic nevi of the scalp.
    J Am Acad Dermatol, 58(3): 508-11. [Abstract] [Full-text]
27. Isolated plantar collagenoma not associated with Proteus syndrome.
    J Am Acad Dermatol, 58(3): 497-9. [Abstract] [Full-text]
28. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
    J Am Acad Dermatol, 58(3): 480-4. [Abstract] [Full-text]
29. Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.
    J Am Acad Dermatol, 58(3): 382-6. [Abstract] [Full-text]
30. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.
    J Am Acad Dermatol, 58(3): 375-81. [Abstract] [Full-text]
31. BRAF kinase in melanoma development and progression.
    Expert Rev Mol Med, 10: e6. [Abstract] [Full-text]
32. Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation.
    Arch Dermatol, 144(2): 186-94. [Abstract] [Full-text]
33. Inciting inflammation: the RAGE about tumor promotion.
    J Exp Med, 205(2): 267-70. [Abstract] [Full-text]
34. RAGE signaling sustains inflammation and promotes tumor development.
    J Exp Med, 205(2): 275-85. [Abstract] [Full-text]
35. The frequency of Muir-Torre syndrome among Lynch syndrome families.
    J Natl Cancer Inst, 100(4): 277-81. [Abstract] [Full-text]
36. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
    Int J Dermatol, 47(3): 276-9. [Abstract] [Full-text]
37. Intertriginous plasmacytosis with plasmoacanthoma: report of a typical case and review of the literature.
    Int J Dermatol, 47(3): 265-8. [Abstract] [Full-text]
38. Primary mucinous carcinoma of the skin: a population-based study.
    Int J Dermatol, 47(3): 242-5. [Abstract] [Full-text]
39. Imaging appearance of diffuse neurofibroma.
    AJR Am J Roentgenol, 190(3): 582-8. [Abstract] [Full-text]
40. Clonal integration of a polyomavirus in human Merkel cell carcinoma.
    Science, 319(5866): 1096-100. [Abstract] [Full-text]
41. Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration.
    Pediatr Blood Cancer, 50(4): 879-81. [Abstract] [Full-text]
42. Chronic metastatic neuroblastoma.
    Pediatr Blood Cancer, 50(4): 898-900. [Abstract] [Full-text]
43. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism.
    Int J Cancer, 122(8): 1787-93. [Abstract] [Full-text]
44. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
    Cancer Immunol Immunother, 57(5): 685-91. [Abstract] [Full-text]
45. Merkel cell cancer: update on biology and treatment.
    Curr Opin Oncol, 20(2): 196-200. [Abstract] [Full-text]
46. Pathobiology of the sentinel node.
    Curr Opin Oncol, 20(2): 190-5. [Abstract] [Full-text]
47. Removal of the outer table of the skull for reconstruction of full-thickness scalp defects with a dermal regeneration template.
    Dermatol Surg, 34(3): 357-63. [Abstract] [Full-text]
48. HSP90 as a marker of progression in melanoma.
    Ann Oncol, 19(3): 590-4. [Abstract] [Full-text]
49. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site.
    Ann Oncol, 19(3): 583-9. [Abstract] [Full-text]
50. The squamous variant of eccrine porocarcinoma: a clinicopathological study of 21 cases.
    J Clin Pathol, 61(3): 361-5. [Abstract] [Full-text]
51. The correlation of regression in primary melanoma with sentinel lymph node status.
    J Clin Pathol, 61(3): 297-300. [Abstract] [Full-text]
52. Melanoma adrenal metastasis: natural history and surgical management.
    Am J Surg, 195(3): 363-8; discussion 368-9. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.